| . | Overall n = 201 . | Redo-TAVI n = 87 . | Plug n = 79 . | Valvuloplasty n = 35 . |
|---|---|---|---|---|
| Mortality | 10 (5.0) | 0 | 8 (10.1) | 2 (5.7) |
| Procedural success | 107 (63.3) | 50 (68.5) | 33 (52.4) | 24 (72.7) |
| Stroke | 3 (1.5) | 2 (2.3) | 1 (1.3) | 0 |
| Myocardial infarction | 0 | 0 | 0 | 0 |
| Coronary obstruction | 3 (1.5) | 1 (1.1) | 1 (1.3) | 1 (2.9) |
| Annular rapture | 2 (1.0) | 1 (1.1) | 0 | 1 (2.9) |
| Cardiac tamponade | 1 (0.5) | 1 (1.1) | 0 | 0 |
| Conversion to surgery | 3 (1.5) | 1 (1.1) | 0 | 2 (5.6) |
| Malposition | 1 (0.6) | 1 (1.1) | NA | NA |
| Device embolization | 1 (0.6) | 0 | 1 (1.3) | NA |
| Vascular complication | 8 (4.0) | 6 (6.9) | 2 (2.6) | 0 |
| Bleeding | 16 (8.0) | 12 (14.1) | 3 (3.8) | 1 (2.8) |
| Acute kidney injury | 11 (5.6) | 5 (5.9) | 4 (5.3) | 2 (5.6) |
| Permanent pacemaker | 23 (11.4) | 14 (16.1) | 7 (9.0) | 2 (5.6) |
| Days in hospitala | 3 [1, 6] | 5 [2, 7.75] | 2 [1, 4] | 1 [1, 4] |
| NYHA functional class | ||||
| I | 49 (32.5) | 20 (32.8) | 20 (34.5) | 9 (28.1) |
| II | 70 (46.1) | 30 (48.4) | 30 (51.7) | 10 (31.2) |
| III | 22 (14.5) | 9 (14.5) | 5 (8.6) | 8 (25.0) |
| IV | 7 (4.6) | 2 (3.2) | 3 (5.2) | 2 (6.2) |
| AV re-intervention | 1 (0.6) | 0 | 0 | 1 (3.1) |
| Mean AV gradient (mmHg) | 10.8 ± 5.2 | 11.2 ± 4.8 | 10.5 ± 5.4 | 10.6 ± 5.9 |
| Max AV gradient (mmHg) | 20.7 ± 9.2 | 20.8 ± 8.0 | 19.9 ± 9.3 | 22.6 ± 12.4 |
| Aortic valve area (cm2) | 1.76 ± 0.49 | 1.67 ± 0.50 | 1.84 ± 0.52 | 1.80 ± 0.41 |
| LVEF (%) | 52 ± 13 | 49 ± 12 | 55 ± 14 | 54 ± 12 |
| . | Overall n = 201 . | Redo-TAVI n = 87 . | Plug n = 79 . | Valvuloplasty n = 35 . |
|---|---|---|---|---|
| Mortality | 10 (5.0) | 0 | 8 (10.1) | 2 (5.7) |
| Procedural success | 107 (63.3) | 50 (68.5) | 33 (52.4) | 24 (72.7) |
| Stroke | 3 (1.5) | 2 (2.3) | 1 (1.3) | 0 |
| Myocardial infarction | 0 | 0 | 0 | 0 |
| Coronary obstruction | 3 (1.5) | 1 (1.1) | 1 (1.3) | 1 (2.9) |
| Annular rapture | 2 (1.0) | 1 (1.1) | 0 | 1 (2.9) |
| Cardiac tamponade | 1 (0.5) | 1 (1.1) | 0 | 0 |
| Conversion to surgery | 3 (1.5) | 1 (1.1) | 0 | 2 (5.6) |
| Malposition | 1 (0.6) | 1 (1.1) | NA | NA |
| Device embolization | 1 (0.6) | 0 | 1 (1.3) | NA |
| Vascular complication | 8 (4.0) | 6 (6.9) | 2 (2.6) | 0 |
| Bleeding | 16 (8.0) | 12 (14.1) | 3 (3.8) | 1 (2.8) |
| Acute kidney injury | 11 (5.6) | 5 (5.9) | 4 (5.3) | 2 (5.6) |
| Permanent pacemaker | 23 (11.4) | 14 (16.1) | 7 (9.0) | 2 (5.6) |
| Days in hospitala | 3 [1, 6] | 5 [2, 7.75] | 2 [1, 4] | 1 [1, 4] |
| NYHA functional class | ||||
| I | 49 (32.5) | 20 (32.8) | 20 (34.5) | 9 (28.1) |
| II | 70 (46.1) | 30 (48.4) | 30 (51.7) | 10 (31.2) |
| III | 22 (14.5) | 9 (14.5) | 5 (8.6) | 8 (25.0) |
| IV | 7 (4.6) | 2 (3.2) | 3 (5.2) | 2 (6.2) |
| AV re-intervention | 1 (0.6) | 0 | 0 | 1 (3.1) |
| Mean AV gradient (mmHg) | 10.8 ± 5.2 | 11.2 ± 4.8 | 10.5 ± 5.4 | 10.6 ± 5.9 |
| Max AV gradient (mmHg) | 20.7 ± 9.2 | 20.8 ± 8.0 | 19.9 ± 9.3 | 22.6 ± 12.4 |
| Aortic valve area (cm2) | 1.76 ± 0.49 | 1.67 ± 0.50 | 1.84 ± 0.52 | 1.80 ± 0.41 |
| LVEF (%) | 52 ± 13 | 49 ± 12 | 55 ± 14 | 54 ± 12 |
Categorical data are reported as n (%); continuous data are reported as mean (standard deviation) or median (interquartile range).
Days in hospital: postoperative.
| . | Overall n = 201 . | Redo-TAVI n = 87 . | Plug n = 79 . | Valvuloplasty n = 35 . |
|---|---|---|---|---|
| Mortality | 10 (5.0) | 0 | 8 (10.1) | 2 (5.7) |
| Procedural success | 107 (63.3) | 50 (68.5) | 33 (52.4) | 24 (72.7) |
| Stroke | 3 (1.5) | 2 (2.3) | 1 (1.3) | 0 |
| Myocardial infarction | 0 | 0 | 0 | 0 |
| Coronary obstruction | 3 (1.5) | 1 (1.1) | 1 (1.3) | 1 (2.9) |
| Annular rapture | 2 (1.0) | 1 (1.1) | 0 | 1 (2.9) |
| Cardiac tamponade | 1 (0.5) | 1 (1.1) | 0 | 0 |
| Conversion to surgery | 3 (1.5) | 1 (1.1) | 0 | 2 (5.6) |
| Malposition | 1 (0.6) | 1 (1.1) | NA | NA |
| Device embolization | 1 (0.6) | 0 | 1 (1.3) | NA |
| Vascular complication | 8 (4.0) | 6 (6.9) | 2 (2.6) | 0 |
| Bleeding | 16 (8.0) | 12 (14.1) | 3 (3.8) | 1 (2.8) |
| Acute kidney injury | 11 (5.6) | 5 (5.9) | 4 (5.3) | 2 (5.6) |
| Permanent pacemaker | 23 (11.4) | 14 (16.1) | 7 (9.0) | 2 (5.6) |
| Days in hospitala | 3 [1, 6] | 5 [2, 7.75] | 2 [1, 4] | 1 [1, 4] |
| NYHA functional class | ||||
| I | 49 (32.5) | 20 (32.8) | 20 (34.5) | 9 (28.1) |
| II | 70 (46.1) | 30 (48.4) | 30 (51.7) | 10 (31.2) |
| III | 22 (14.5) | 9 (14.5) | 5 (8.6) | 8 (25.0) |
| IV | 7 (4.6) | 2 (3.2) | 3 (5.2) | 2 (6.2) |
| AV re-intervention | 1 (0.6) | 0 | 0 | 1 (3.1) |
| Mean AV gradient (mmHg) | 10.8 ± 5.2 | 11.2 ± 4.8 | 10.5 ± 5.4 | 10.6 ± 5.9 |
| Max AV gradient (mmHg) | 20.7 ± 9.2 | 20.8 ± 8.0 | 19.9 ± 9.3 | 22.6 ± 12.4 |
| Aortic valve area (cm2) | 1.76 ± 0.49 | 1.67 ± 0.50 | 1.84 ± 0.52 | 1.80 ± 0.41 |
| LVEF (%) | 52 ± 13 | 49 ± 12 | 55 ± 14 | 54 ± 12 |
| . | Overall n = 201 . | Redo-TAVI n = 87 . | Plug n = 79 . | Valvuloplasty n = 35 . |
|---|---|---|---|---|
| Mortality | 10 (5.0) | 0 | 8 (10.1) | 2 (5.7) |
| Procedural success | 107 (63.3) | 50 (68.5) | 33 (52.4) | 24 (72.7) |
| Stroke | 3 (1.5) | 2 (2.3) | 1 (1.3) | 0 |
| Myocardial infarction | 0 | 0 | 0 | 0 |
| Coronary obstruction | 3 (1.5) | 1 (1.1) | 1 (1.3) | 1 (2.9) |
| Annular rapture | 2 (1.0) | 1 (1.1) | 0 | 1 (2.9) |
| Cardiac tamponade | 1 (0.5) | 1 (1.1) | 0 | 0 |
| Conversion to surgery | 3 (1.5) | 1 (1.1) | 0 | 2 (5.6) |
| Malposition | 1 (0.6) | 1 (1.1) | NA | NA |
| Device embolization | 1 (0.6) | 0 | 1 (1.3) | NA |
| Vascular complication | 8 (4.0) | 6 (6.9) | 2 (2.6) | 0 |
| Bleeding | 16 (8.0) | 12 (14.1) | 3 (3.8) | 1 (2.8) |
| Acute kidney injury | 11 (5.6) | 5 (5.9) | 4 (5.3) | 2 (5.6) |
| Permanent pacemaker | 23 (11.4) | 14 (16.1) | 7 (9.0) | 2 (5.6) |
| Days in hospitala | 3 [1, 6] | 5 [2, 7.75] | 2 [1, 4] | 1 [1, 4] |
| NYHA functional class | ||||
| I | 49 (32.5) | 20 (32.8) | 20 (34.5) | 9 (28.1) |
| II | 70 (46.1) | 30 (48.4) | 30 (51.7) | 10 (31.2) |
| III | 22 (14.5) | 9 (14.5) | 5 (8.6) | 8 (25.0) |
| IV | 7 (4.6) | 2 (3.2) | 3 (5.2) | 2 (6.2) |
| AV re-intervention | 1 (0.6) | 0 | 0 | 1 (3.1) |
| Mean AV gradient (mmHg) | 10.8 ± 5.2 | 11.2 ± 4.8 | 10.5 ± 5.4 | 10.6 ± 5.9 |
| Max AV gradient (mmHg) | 20.7 ± 9.2 | 20.8 ± 8.0 | 19.9 ± 9.3 | 22.6 ± 12.4 |
| Aortic valve area (cm2) | 1.76 ± 0.49 | 1.67 ± 0.50 | 1.84 ± 0.52 | 1.80 ± 0.41 |
| LVEF (%) | 52 ± 13 | 49 ± 12 | 55 ± 14 | 54 ± 12 |
Categorical data are reported as n (%); continuous data are reported as mean (standard deviation) or median (interquartile range).
Days in hospital: postoperative.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
